Search

everythinglearnresearchcommunity

for

Search:↓

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Treatment during development affects hormone balance and sexual behavior in male rats.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Finasteride causes harmful organ changes in female mice.

Higher testosterone in females with PCOS is linked to depression and cognitive issues, but anti-androgen treatment can help.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.

The traditional treatment was more effective than finasteride for androgenic alopecia.

Pterocarpus indcus Willd extracts taken orally can reduce hair loss in rats.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.